Fankai Meng

2.2k total citations
70 papers, 1.1k citations indexed

About

Fankai Meng is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Fankai Meng has authored 70 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Oncology, 27 papers in Molecular Biology and 18 papers in Hematology. Recurrent topics in Fankai Meng's work include CAR-T cell therapy research (20 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Fankai Meng is often cited by papers focused on CAR-T cell therapy research (20 papers), Hematopoietic Stem Cell Transplantation (9 papers) and Lymphoma Diagnosis and Treatment (9 papers). Fankai Meng collaborates with scholars based in China, Japan and United States. Fankai Meng's co-authors include Minghao Fang, Ruichao Li, Shun Ke, Pengfei Ge, Yinan Luo, Jianfeng Zhou, Jun Lü, Jia Wei, Zhigang He and Xiaojian Zhu and has published in prestigious journals such as Blood, International Journal of Cancer and Frontiers in Immunology.

In The Last Decade

Fankai Meng

63 papers receiving 1.1k citations

Peers

Countries citing papers authored by Fankai Meng

Since Specialization

Citations

This map shows the geographic impact of Fankai Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fankai Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fankai Meng more than expected).

Fields of papers citing papers by Fankai Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fankai Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fankai Meng. The network helps show where Fankai Meng may publish in the future.

Co-authorship network of co-authors of Fankai Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Fankai Meng. A scholar is included among the top collaborators of Fankai Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fankai Meng. Fankai Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL 2025 ·Blood Cancer Discovery ·(unknown), Jue Wang, Na Wang, (unknown), Jinhuan Xu, Xiaojian Zhu, (unknown), (unknown), Fankai Meng, Yi Xiao, Miao Zheng, (unknown), Chunrui Li, Jia Wei, Yang Cao, (unknown)	0
2	Development of a Diagnostic Algorithm for Epstein‐Barr Virus‐Related Diseases: A Retrospective Observational Study 2025 ·Journal of Medical Virology ·Jiaoyuan Li, Hongyan Hou, Juan Song, Yuan Xu, (unknown), Ke Yang, Peipei Wang, (unknown), Dong Kuang, Ziyong Sun, Fankai Meng, Jing Peng, Liming Cheng	1
3	Prognostic differences between carmustine, etoposide, cytarabine and melphalan (BEAM) and carmustine, etoposide, cytarabine, melphalan and fludarabine (BEAMF) regimens before autologous stem cell transplantation plus chimeric antigen receptor T therapy in patients with refractory/relapsed B-cell non-Hodgkin-lymphoma 2024 ·Cytotherapy ·(unknown), Li Lin, Yang Yang, Na Wang, Jue Wang, Jinhuan Xu, Jia Wei, Liang Huang, Miao Zheng, Yi Xiao, Fankai Meng, Yang Cao, Xiaojian Zhu, Yicheng Zhang	2
4	Recombinant Human Thrombopoietin Promotes Platelet Engraftment in Severe Aplastic Anemia Patients Following Treatment With Haploid Hematopoietic Stem Cell Transplantation using Modified Post-Transplantation Cyclophosphamide 2024 ·Transplantation and Cellular Therapy ·(unknown), (unknown), (unknown), Jiaying Wu, Xiaojian Zhu, (unknown), Lifang Huang, Na Wang, Jue Wang, Jinhuan Xu, (unknown), Yang Cao, Jia Wei, Yi Xiao, Fankai Meng, Hui Cheng, Yicheng Zhang, Donghua Zhang	4
5	Clinical outcomes of chimeric antigen receptor T-cell therapy following autologous hematopoietic stem cell transplantation in 38 patients with refractory/relapsed primary or secondary central nervous system lymphoma 2024 ·Cancer Immunology Immunotherapy ·(unknown), Wanying Liu, Yang Cao, Yang Yang, Zhen Shang, Mi Zhou, Yicheng Zhang, Fankai Meng, Xiaojian Zhu, Yi Xiao	1
6	Peripheral Blood Smears Distinguish Infective Fever after CAR-T Therapy 2023 ·Frontiers in Bioscience-Landmark ·(unknown), Juan‐juan Peng, (unknown), Fankai Meng, Liang Huang, (unknown), (unknown), (unknown), (unknown), Zhiqiong Wang, Jia Wei	1
7	CD26 CAR-T cells have attenuated mitochondrial and glycolytic metabolic profiling 2023 ·Immunopharmacology and Immunotoxicology ·Xiaoying Zhu, Zhaodong Zhong, Fankai Meng, Ping Zou, (unknown), Qing Li, Xiaojian Zhu	1
8	CAR19/22 T cell cocktail therapy for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation 2022 ·Cytotherapy ·(unknown), Na Wang, Gaoxiang Wang, Liang Huang, Chunrui Li, Di Wang, Jue Wang, Lifang Huang, Fankai Meng, Jia Wei, Liting Chen, Xia Mao, Jianfeng Zhou, Yicheng Zhang, Yang Cao	14
9	Efficacy and safety of chimeric antigen receptor T-cell therapy targeting CD19/CD22 in refractory/relapsed transformed aggressive B-cell lymphoma 2022 ·Cytotherapy ·Hao Xu, (unknown), Liang Huang, Wenyue Cao, Jue Wang, Fankai Meng, Chunrui Li, Miao Zheng, Liting Chen, Ketao Mu, Jiali Cheng, Li Zhu, Jianfeng Zhou, Yicheng Zhang, Na Wang, Yang Cao	2
10	Comparisons of Modified Post-Transplantation Cyclophosphamide and Granulocyte Colony-Stimulating Factor/Antithymocyte Globulin Regimens for Haploidentical Stem Cell Transplantation in Patients with Aplastic Anemia 2022 ·Transplantation and Cellular Therapy ·Yun Li, Xuan Lu, Na Wang, Xiaoying Zhang, Yang Cao, Yi Xiao, Fankai Meng, Donghua Zhang, (unknown), Liang Zou, Hui Cheng, Jing-Ming Guo, Youshan Zhang, Zhiping Huang, Guolin Yuan, Jia Wei, Huafang Wang, Linghui Xia, Yicheng Zhang	6
11	Frontline Therapy Options for Adults With Newly Diagnosed Severe Aplastic Anemia: Intensive immunosuppressive Therapy Plus Eltrombopag or Matched Sibling Donor Hematopoietic Stem Cell Transplantation? 2022 ·Transplantation and Cellular Therapy ·Lifang Huang, Li Li, Jinsong Jia, Yan Yang, (unknown), Fankai Meng, Donghua Zhang, Guangsheng He	7
12	Clinical characteristics of hematological patients concomitant with COVID‐19 2020 ·Cancer Science ·Xiaoxi Zhou, Gaoxiang Wang, Liting Chen, Fankai Meng, Liang Huang, Lifang Huang, Na Wang, (unknown), Yang Cao, Jianfeng Zhou	12
13	CAR T-Cell Therapy Is Effective but Not Long-Lasting in B-Cell Lymphoma of the Brain 2020 ·Frontiers in Oncology ·(unknown), Lei Zhao, Yuanyuan Zhang, Yi Xiao, Di Wang, Liang Huang, Liya Ma, Liting Chen, (unknown), Xiaolu Long, Fankai Meng, Xiaojian Zhu, Jia Wei, (unknown), Jianfeng Zhou, Xiaoxi Zhou	32
14	CiRS-7 promotes growth and metastasis of esophageal squamous cell carcinoma via regulation of miR-7/HOXB13 2018 ·Cell Death and Disease ·Ruichao Li, Shun Ke, Fankai Meng, Jun Lü, Xiaojing Zou, Zhigang He, (unknown), Minghao Fang	167
15	Expression of autophagy in different stages of neurogenic bladder after spinal cord injury in rats 2017 ·Spinal Cord ·(unknown), (unknown), (unknown), (unknown), (unknown), Manyi Sun, (unknown), Fankai Meng, (unknown), Dongqi Wang, (unknown)	5
16	RIP1 and RIP3 contribute to shikonin-induced DNA double-strand breaks in glioma cells via increase of intracellular reactive oxygen species 2017 ·Cancer Letters ·(unknown), Bin Lü, Chen Wang, Zongqi Wang, Tianfei Luo, Meihua Piao, Fankai Meng, Guangfan Chi, Yinan Luo, Pengfei Ge	55
17	MicroRNA-192 regulates cell proliferation and cell cycle transition in acute myeloid leukemia via interaction with CCNT2 2017 ·International Journal of Hematology ·Shun Ke, Ruichao Li, Jun Lü, Fankai Meng, (unknown), Minghao Fang	35
18	Shikonin induces glioma cell necroptosis in vitro by ROS overproduction and promoting RIP1/RIP3 necrosome formation 2017 ·Acta Pharmacologica Sinica ·Bin Lü, Xu Gong, Zongqi Wang, Ye Ding, Chen Wang, Tianfei Luo, Meihua Piao, Fankai Meng, Guangfan Chi, Yinan Luo, Pengfei Ge	115
19	Association between glutathione S-transferase T1 null genotype and risk of myelodysplastic syndromes: a comprehensive meta-analysis 2013 ·Tumor Biology ·Minghao Fang, Wen Zeng, Lifang Huang, Shuang Qin, Jianfeng Zhou, (unknown), Fankai Meng	2
20	Study on expression of VEGF in murine bone marrow stromal cells with radiation injury and its significance 2004 ·Lan Sun, Wenli Liu, Sun Hanying, (unknown), Fankai Meng, (unknown), Lu Wu	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact